# TYENNE
> **BLA761449** · Biologics License Application · Sponsor: FRESENIUS KABI USA · Approved 2025-03-14
## Drug
- **FDA Application Number:** BLA761449
- **Application type:** Biologics License Application
- **Brand name:** TYENNE
- **Generic name:** TOCILIZUMAB-AAZG
- **Active ingredients:** TOCILIZUMAB-AAZG
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2025-03-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761449)
---
*MORVS · CC0 1.0*